[From tumor necrosis factor to TRAIL-AMAIZe: second generation antitumorally effective cytokines].
Wajant
H
H
Institut für Zellbiologie und Immunologie, Universität Stuttgart.
Pfizenmaier
K
K
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D051017:Apoptosis Regulatory Proteins; D016207:Cytokines / Q000502:physiology*; D006801:Humans; D008562:Membrane Glycoproteins / Q000502:physiology; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D053221:TNF-Related Apoptosis-Inducing Ligand; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology*
D051017:Apoptosis Regulatory Proteins; D016207:Cytokines; D008562:Membrane Glycoproteins; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha